Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Given previous evidence of Layer II/III and V pyramidal cell alterations in schizophrenia and the significant influence of subunit composition on NMDA and AMPA receptor function, laser capture microdissection combined with quantitative PCR was used to examine the expression of AMPA (GRIA1-4) and NMDA (GRIN1, 2A and 2B) subunit mRNA levels in Layer II/III and Layer V pyramidal cells in the DLPFC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP215732.RA_vGTBYJEDrc8TVtgxTDT7z2NYkukp6KHx3pkKu2pOmE130_assertion description "[Given previous evidence of Layer II/III and V pyramidal cell alterations in schizophrenia and the significant influence of subunit composition on NMDA and AMPA receptor function, laser capture microdissection combined with quantitative PCR was used to examine the expression of AMPA (GRIA1-4) and NMDA (GRIN1, 2A and 2B) subunit mRNA levels in Layer II/III and Layer V pyramidal cells in the DLPFC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP215732.RA_vGTBYJEDrc8TVtgxTDT7z2NYkukp6KHx3pkKu2pOmE130_provenance.
• NP223303.RA5oA45CZkKDtq-mV7erLIulBh52rd7K-rjHhl9jubIsM130_assertion description "[Given previous evidence of Layer II/III and V pyramidal cell alterations in schizophrenia and the significant influence of subunit composition on NMDA and AMPA receptor function, laser capture microdissection combined with quantitative PCR was used to examine the expression of AMPA (GRIA1-4) and NMDA (GRIN1, 2A and 2B) subunit mRNA levels in Layer II/III and Layer V pyramidal cells in the DLPFC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP223303.RA5oA45CZkKDtq-mV7erLIulBh52rd7K-rjHhl9jubIsM130_provenance.
• NP369697.RAD-EFRZIZ6Id47H9xRNrBqwSpDE76orGI_vVPaDeIW9M130_assertion description "[Given previous evidence of Layer II/III and V pyramidal cell alterations in schizophrenia and the significant influence of subunit composition on NMDA and AMPA receptor function, laser capture microdissection combined with quantitative PCR was used to examine the expression of AMPA (GRIA1-4) and NMDA (GRIN1, 2A and 2B) subunit mRNA levels in Layer II/III and Layer V pyramidal cells in the DLPFC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369697.RAD-EFRZIZ6Id47H9xRNrBqwSpDE76orGI_vVPaDeIW9M130_provenance.
• NP581668.RAnGkREic8ZUP3Vq_Uwbm2La_ut5O_D7s15xVgzSdVjTU130_assertion description "[Given previous evidence of Layer II/III and V pyramidal cell alterations in schizophrenia and the significant influence of subunit composition on NMDA and AMPA receptor function, laser capture microdissection combined with quantitative PCR was used to examine the expression of AMPA (GRIA1-4) and NMDA (GRIN1, 2A and 2B) subunit mRNA levels in Layer II/III and Layer V pyramidal cells in the DLPFC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581668.RAnGkREic8ZUP3Vq_Uwbm2La_ut5O_D7s15xVgzSdVjTU130_provenance.
• NP372644.RAfU0kGd_L0eaaZgSJq2BoxzrM4L63PxoHhhwUHvHRME8130_assertion description "[Given previous evidence of Layer II/III and V pyramidal cell alterations in schizophrenia and the significant influence of subunit composition on NMDA and AMPA receptor function, laser capture microdissection combined with quantitative PCR was used to examine the expression of AMPA (GRIA1-4) and NMDA (GRIN1, 2A and 2B) subunit mRNA levels in Layer II/III and Layer V pyramidal cells in the DLPFC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372644.RAfU0kGd_L0eaaZgSJq2BoxzrM4L63PxoHhhwUHvHRME8130_provenance.
• NP716650.RABabFjhTHJH9TGBUbI6u_TnNCwydlHSTUuvCSin5jR0s130_assertion description "[Given previous evidence of Layer II/III and V pyramidal cell alterations in schizophrenia and the significant influence of subunit composition on NMDA and AMPA receptor function, laser capture microdissection combined with quantitative PCR was used to examine the expression of AMPA (GRIA1-4) and NMDA (GRIN1, 2A and 2B) subunit mRNA levels in Layer II/III and Layer V pyramidal cells in the DLPFC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP716650.RABabFjhTHJH9TGBUbI6u_TnNCwydlHSTUuvCSin5jR0s130_provenance.
• NP590869.RAXkmy3NeXxujHSHlUo3d7_it4tPW8gVxlfK_HGRy5D0M130_assertion description "[Given previous evidence of Layer II/III and V pyramidal cell alterations in schizophrenia and the significant influence of subunit composition on NMDA and AMPA receptor function, laser capture microdissection combined with quantitative PCR was used to examine the expression of AMPA (GRIA1-4) and NMDA (GRIN1, 2A and 2B) subunit mRNA levels in Layer II/III and Layer V pyramidal cells in the DLPFC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP590869.RAXkmy3NeXxujHSHlUo3d7_it4tPW8gVxlfK_HGRy5D0M130_provenance.
• assertion description "[Given previous evidence of Layer II/III and V pyramidal cell alterations in schizophrenia and the significant influence of subunit composition on NMDA and AMPA receptor function, laser capture microdissection combined with quantitative PCR was used to examine the expression of AMPA (GRIA1-4) and NMDA (GRIN1, 2A and 2B) subunit mRNA levels in Layer II/III and Layer V pyramidal cells in the DLPFC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP434444.RA9GfTKcotw53nWOcf8BuBmjfWw_FbiXUEmzwEf2DtLVY130_assertion description "[Given previous evidence of Layer II/III and V pyramidal cell alterations in schizophrenia and the significant influence of subunit composition on NMDA and AMPA receptor function, laser capture microdissection combined with quantitative PCR was used to examine the expression of AMPA (GRIA1-4) and NMDA (GRIN1, 2A and 2B) subunit mRNA levels in Layer II/III and Layer V pyramidal cells in the DLPFC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434444.RA9GfTKcotw53nWOcf8BuBmjfWw_FbiXUEmzwEf2DtLVY130_provenance.
• NP965195.RAHbUPbQuUFESilq0K2ZUldYCGlLPDsYtQNvQwN5yCQUc130_assertion description "[Given previous evidence of Layer II/III and V pyramidal cell alterations in schizophrenia and the significant influence of subunit composition on NMDA and AMPA receptor function, laser capture microdissection combined with quantitative PCR was used to examine the expression of AMPA (GRIA1-4) and NMDA (GRIN1, 2A and 2B) subunit mRNA levels in Layer II/III and Layer V pyramidal cells in the DLPFC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965195.RAHbUPbQuUFESilq0K2ZUldYCGlLPDsYtQNvQwN5yCQUc130_provenance.
• NP635752.RAEQ9fMxybKAMfq12RO6MeRWBW_OC3QOERatA7ozn8UtM130_assertion description "[Given previous evidence of Layer II/III and V pyramidal cell alterations in schizophrenia and the significant influence of subunit composition on NMDA and AMPA receptor function, laser capture microdissection combined with quantitative PCR was used to examine the expression of AMPA (GRIA1-4) and NMDA (GRIN1, 2A and 2B) subunit mRNA levels in Layer II/III and Layer V pyramidal cells in the DLPFC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635752.RAEQ9fMxybKAMfq12RO6MeRWBW_OC3QOERatA7ozn8UtM130_provenance.
• NP635753.RAyH4Ac9qQCtqaeaMpTjNP0_X03xPYKnUA9CLQRUsK-yg130_assertion description "[Given previous evidence of Layer II/III and V pyramidal cell alterations in schizophrenia and the significant influence of subunit composition on NMDA and AMPA receptor function, laser capture microdissection combined with quantitative PCR was used to examine the expression of AMPA (GRIA1-4) and NMDA (GRIN1, 2A and 2B) subunit mRNA levels in Layer II/III and Layer V pyramidal cells in the DLPFC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635753.RAyH4Ac9qQCtqaeaMpTjNP0_X03xPYKnUA9CLQRUsK-yg130_provenance.